Sector portfolio · Corporate investor · United States

Access Industries' Biotech portfolio

Access Industries has backed 11 Biotech startups in rounds we track, $1.6B between them, shown by the stage each has reached. The best-funded is Passage Bio.

11startups backed
2stages
$1.6Braised between them
Series Bbiggest stage

Access Industries's profile

Segment by segment

Series B

7 startups · $1.2B raised

  1. Passage BioPassage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.United States$380M
  2. HumacyteHumacyte, Inc.United States$297M
  3. Matchpoint TherapeuticsMatchpoint Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021.United States$220M
  4. Neon TherapeuticsNEON Therapeutics is focused on unlocking the full potential of the immune system to recognize and attack cancer.United States$161M
  5. MTMagenta TherpeuticsUnited States$50M
  6. CTCadent TherapeuticsCadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.United States$40M
  7. EEIPUnited States$21M

Series A

4 startups · $412M raised

  1. Disc MedicineDisc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.United States$275M
  2. VTVima TherapeuticsUnited States$100M
  3. TTTrefoil TherapueitcsUnited States$28M
  4. NextGen넥스트젠은 크리에이터 수익화 플랫폼입니다.United States$9.0M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Access Industries as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios

Raising from investors like Access Industries?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.